Demographic, healthcare access, and dietary factors associated with thyroid hormone treatments for hypothyroidism.
Matthew D EttlesonSabrina IbarraWen WanSarah PetersonNeda LaiteerapongAntonio Carlos BiancoPublished in: The Journal of clinical endocrinology and metabolism (2023)
The proportion of new TH therapies containing DTE for hypothyroidism doubled since 2010 while LT3 therapies remained stable. DTE treatment was associated with decreased physician density and increased dietary supplement use.